BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 11369440)

  • 21. Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells.
    Kleeff J; Korc M
    J Biol Chem; 1998 Mar; 273(13):7495-500. PubMed ID: 9516449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells.
    Yamato K; Koseki T; Ohguchi M; Kizaki M; Ikeda Y; Nishihara T
    Mol Endocrinol; 1997 Jul; 11(8):1044-52. PubMed ID: 9212052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b).
    Malumbres M; Pérez De Castro I; Hernández MI; Jiménez M; Corral T; Pellicer A
    Mol Cell Biol; 2000 Apr; 20(8):2915-25. PubMed ID: 10733595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin A down-regulation in TGFbeta1-arrested follicular lymphoma cells.
    Djaborkhel R; Tvrdík D; Eckschlager T; Raska I; Müller J
    Exp Cell Res; 2000 Nov; 261(1):250-9. PubMed ID: 11082295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
    Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC; Chen YQ
    Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
    Iavarone A; Massagué J
    Nature; 1997 May; 387(6631):417-22. PubMed ID: 9163429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFbeta/IL-7 inhibitory signaling mechanism.
    Urashima M; Hoshi Y; Sugimoto Y; Kaihara C; Matsuzaki M; Chauhan D; Ogata A; Teoh G; DeCaprio JA; Anderson KC
    Leukemia; 1996 Oct; 10(10):1576-83. PubMed ID: 8847892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between endogenous gene expression and growth regulation induced by TGF-beta1 in human gastric cancer cells.
    Li X; Zhang YY; Wang Q; Fu SB
    World J Gastroenterol; 2005 Jan; 11(1):61-8. PubMed ID: 15609398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
    Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM
    Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rb independent inhibition of cell growth by p15(INK4B).
    Aytac U; Konishi T; David H; Mendoza S; Miller CW
    Biochem Biophys Res Commun; 1999 Aug; 262(2):534-8. PubMed ID: 10462509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-epidermal growth factor receptor monoclonal antibody 225 upregulates p27(KIP1) and p15(INK4B) and induces G1 arrest in oral squamous carcinoma cell lines.
    Kiyota A; Shintani S; Mihara M; Nakahara Y; Ueyama Y; Matsumura T; Tachikawa T; Wong DT
    Oncology; 2002; 63(1):92-8. PubMed ID: 12187077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baicalein induces a dual growth arrest by modulating multiple cell cycle regulatory molecules.
    Hsu SL; Hsieh YC; Hsieh WC; Chou CJ
    Eur J Pharmacol; 2001 Aug; 425(3):165-71. PubMed ID: 11513834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
    Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
    Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells.
    Sandhu C; Garbe J; Bhattacharya N; Daksis J; Pan CH; Yaswen P; Koh J; Slingerland JM; Stampfer MR
    Mol Cell Biol; 1997 May; 17(5):2458-67. PubMed ID: 9111314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells.
    Mazars P; Barboule N; Baldin V; Vidal S; Ducommun B; Valette A
    FEBS Lett; 1995 Apr; 362(3):295-300. PubMed ID: 7729516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A potential role for p15(Ink4b) and p57(Kip2) in liver development.
    Awad MM; Sanders JA; Gruppuso PA
    FEBS Lett; 2000 Oct; 483(2-3):160-4. PubMed ID: 11042273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.